5-minute read
Part 1: Drug Rationing Is the Wrong Prescription
The adverse effects of policies aiming to reduce public expenses on prescription drugs.
4-minute read
Why Public Health Activists Want to Hide Inconvenient Truths
The ineffectiveness of a fat tax.
3-minute read
The economic cost of surgery wait times
The surgical wait times in Canada.
3-minute read
Rationing drugs is not the way to cut costs
A pan-Canadian, government-run drug insurance plan.
1-minute read
Wrong Prescription: The Unintended Consequences of Pharmaceutical Cost Containment Policies
The obsession with reducing public spending on prescription drugs, which takes the form of constantly falling price caps, bulk purchasing strategies and reimbursement restrictions, entails numerous unintended consequences, especially for the health of Canadians. These are the findings of a new study from the Montreal Economic Institute (MEI).
Media release :: Government monopoly would reduce the quality of prescription drug coverage
4-minute read
The Nasty Side Effects of a National Drug Plan
A new national drug plan.
5-minute read
National Pharmascare
A new national drug plan.
3-minute read
Canada could learn from Germany’s private hospitals
Germany's health-care system.
3-minute read
Taxes will make obesity even costlier
A global and non-coercive approach to fighting obesity.
1-minute read
No Magic Pill: Positive Solutions to the Obesity Issue
In recent years, we have witnessed the emergence of groups that, in the name of public health, seek greater government supervision over our daily lives. This can take the form of taxes or regulations, as the case may be. When it comes to the phenomenon of obesity, the Research Paper by Dr. David Gratzer, in collaboration with Jasmin Guénette, suggests a positive approach that takes account of the complexity of the problem rather than turning to a tax on specific products, a route that has failed to deliver the hoped-for results, as explained in a previous MEI Economic Note.